Jafron Biomedical Co EBITDA

EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of Jafron Biomedical Co is 1.10 B CNY in 2026.

EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of Jafron Biomedical Co changed from 585.26 M CNY to 1.10 B CNY, representing a 88.33% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) Jafron Biomedical Co since 2006 – with annual values, charts, and detailed analysis.

EBITDA measures operating performance before the impact of financial structure, tax environment, and non-cash depreciation charges.

EBITDA = EBIT + Depreciation & Amortization

EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization)'s CNY is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization)'s Jafron Biomedical Co historically and in real time.